Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant: COVID-19 - Transmission dynamics/animal host/modeling

University of British Columbia

$1,000,000.00

Rapid Response to Emerging Serious Pathogen Outbreaks using Next-gen Data: R2ESPOND

EF 2019-20

Résumé
A new virus has been identified from Wuhan City in China from the coronavirus family (SARS-CoV-2), which is now responsible for more than 71,000 cases of illness (COVID-19 disease) in over 29 countries. Although there have not yet been any deaths in Canada, public health agencies are on high alert, as there is a real possibility of a serious epidemic. The WHO has declared COVID-19 a public health emergency of international concern. As of February 14th, five COVID-19 cases have been confirmed in British Columbia and based on travel patterns there is every reason to expect additional cases in BC. There are many unanswered questions regarding the virus, how it spreads and the disease that it causes. This information is needed for a data-driven response to this outbreak. We aim to use two types of next-generation data (next-gen genomics data and next-gen human data), along with a data integration tool called PLOVER 2.0, to answer these unknowns. The research team will 1)Carry out rapid genomic sequencing on patient samples to study the virus, how it spreads, how it evolves and predict which drugs will work 2)Develop knowledge of how the virus characteristics, along with a patient's previous health conditions, impact the severity of illness and how they recover from the illness 3)Develop a software tool (PLOVER 2.0) that will allow us to carry out this research and will also make the data viewable by key stakeholders such as Medical Health Officers. This work will not only generate critical knowledge about the SARS-CoV-2 virus but will also help develop a better understanding of health outcomes for infected patients. The knowledge generated and tools developed by this research can ensure an evidence-based and cohesive response to this public health emergency, here in Canada and internationally.
Programme
Operating Grant: COVID-19 - Transmission dynamics/animal host/modeling
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
422748
Name
Prystajecky Natalie Anne
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Canadian 2019 Novel Coronavirus (2019-nCoV) Rapid Research
Projecttitle
Rapid Response to Emerging Serious Pathogen Outbreaks using Next-gen Data: R2ESPOND
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$1,000,000
Cihrequipment2
$0
Programname2
Operating Grant: COVID-19 - Transmission dynamics/animal host/modeling
Keyworddelim
Clinical Data; Covid-19; Data Integration; Genomics; Information Management; Outbreak Response; Outcome Data; Phylogenetics; Sars-Cov-19; Virology
Abstract
A new virus has been identified from Wuhan City in China from the coronavirus family (SARS-CoV-2), which is now responsible for more than 71,000 cases of illness (COVID-19 disease) in over 29 countries. Although there have not yet been any deaths in Canada, public health agencies are on high alert, as there is a real possibility of a serious epidemic. The WHO has declared COVID-19 a public health emergency of international concern. As of February 14th, five COVID-19 cases have been confirmed in British Columbia and based on travel patterns there is every reason to expect additional cases in BC. There are many unanswered questions regarding the virus, how it spreads and the disease that it causes. This information is needed for a data-driven response to this outbreak. We aim to use two types of next-generation data (next-gen genomics data and next-gen human data), along with a data integration tool called PLOVER 2.0, to answer these unknowns. The research team will 1)Carry out rapid genomic sequencing on patient samples to study the virus, how it spreads, how it evolves and predict which drugs will work 2)Develop knowledge of how the virus characteristics, along with a patient's previous health conditions, impact the severity of illness and how they recover from the illness 3)Develop a software tool (PLOVER 2.0) that will allow us to carry out this research and will also make the data viewable by key stakeholders such as Medical Health Officers. This work will not only generate critical knowledge about the SARS-CoV-2 virus but will also help develop a better understanding of health outcomes for infected patients. The knowledge generated and tools developed by this research can ensure an evidence-based and cohesive response to this public health emergency, here in Canada and internationally.
Competitiondate
202002
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Prystajecky, Natalie Anne; Krajden, Mel
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $1,000,000~ $0~